Neuroprotective effects of protocatechuic aldehyde through PLK2/p-GSK3β/Nrf2 signaling pathway in both <i>in vivo</i> and <i>in vitro</i> models of Parkinson's disease.

Aging (Albany NY) · 2019 · PMC6874433 · PMID 31697645

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The dosage of 10 mg/kg of PCA showed a decreased trend for the time compared with the MPTP group, which did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.